[go: up one dir, main page]

EP1144265A2 - Seal for a liquid container - Google Patents

Seal for a liquid container

Info

Publication number
EP1144265A2
EP1144265A2 EP99930899A EP99930899A EP1144265A2 EP 1144265 A2 EP1144265 A2 EP 1144265A2 EP 99930899 A EP99930899 A EP 99930899A EP 99930899 A EP99930899 A EP 99930899A EP 1144265 A2 EP1144265 A2 EP 1144265A2
Authority
EP
European Patent Office
Prior art keywords
film
closure
liquid
liquid container
lower film
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
EP99930899A
Other languages
German (de)
French (fr)
Other versions
EP1144265B1 (en
Inventor
Uwe Teuchert
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of EP1144265A2 publication Critical patent/EP1144265A2/en
Application granted granted Critical
Publication of EP1144265B1 publication Critical patent/EP1144265B1/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • BPERFORMING OPERATIONS; TRANSPORTING
    • B65CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65DCONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
    • B65D51/00Closures not otherwise provided for
    • B65D51/24Closures not otherwise provided for combined or co-operating with auxiliary devices for non-closing purposes
    • B65D51/28Closures not otherwise provided for combined or co-operating with auxiliary devices for non-closing purposes with auxiliary containers for additional articles or materials
    • B65D51/2807Closures not otherwise provided for combined or co-operating with auxiliary devices for non-closing purposes with auxiliary containers for additional articles or materials the closure presenting means for placing the additional articles or materials in contact with the main contents by acting on a part of the closure without removing the closure, e.g. by pushing down, pulling up, rotating or turning a part of the closure, or upon initial opening of the container
    • B65D51/2814Closures not otherwise provided for combined or co-operating with auxiliary devices for non-closing purposes with auxiliary containers for additional articles or materials the closure presenting means for placing the additional articles or materials in contact with the main contents by acting on a part of the closure without removing the closure, e.g. by pushing down, pulling up, rotating or turning a part of the closure, or upon initial opening of the container the additional article or materials being released by piercing, cutting or tearing an element enclosing it
    • B65D51/2828Closures not otherwise provided for combined or co-operating with auxiliary devices for non-closing purposes with auxiliary containers for additional articles or materials the closure presenting means for placing the additional articles or materials in contact with the main contents by acting on a part of the closure without removing the closure, e.g. by pushing down, pulling up, rotating or turning a part of the closure, or upon initial opening of the container the additional article or materials being released by piercing, cutting or tearing an element enclosing it said element being a film or a foil
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61JCONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/03Containers specially adapted for medical or pharmaceutical purposes for pills or tablets

Definitions

  • Containers for holding beverages or food are already known, at the opening of which a collar-shaped edge flange is molded.
  • the container closure consists of a film, preferably an aluminum film, which is detachably and liquid-tightly connected to the edge flange.
  • a tab is also regularly provided, which protrudes beyond the edge flange and which enables the film to be pulled off the container opening.
  • Press-through packaging which is also known as blister packaging, for receiving medicaments or food supplements in the form of tablets, pills or dragees is also known.
  • These packages consist of two films arranged one above the other and connected to one another, convex bulges for receiving a medicament or a food supplement in tablet form are formed in the upper film and the flat side of the upper film is covered by the lower film.
  • the upper film is primarily a plastic film and the lower film is an aluminum film.
  • EGG RULE 26 Form are relatively unstable and can not be stored for a long time or change their effects, so that the liquid dosage form only has to be prepared if necessary. This is complex, especially since an exact dosage between the medication and the liquid must sometimes be observed and a germ-free production must be ensured.
  • the object of the present invention is therefore to create a closure for liquid containers which is detachably but liquid-tightly connected to a collar-shaped edge flange formed on the opening of the liquid container and which is germ-free and sealed against the external environment and also against the container interior sealed storage of a medicament or nutritional supplement until it is used together with a liquid and which also enables the preparation of a dispersion or suspension of the medicament or nutritional supplement and the liquid in the container before opening the liquid container.
  • this object is achieved by means of two foils arranged one above the other, between which a cavity is formed for receiving the medicament or food supplement.
  • This cavity is formed by a centrally arranged, convex, cup-shaped bulge in the upper film and the lower film covering the flat side of the upper film.
  • the flat surface of the upper film and the surface of the lower film covering this are at least partially connected to one another by gluing or welding.
  • the upper and the lower film are glued or welded to one another only at their peripheral edge.
  • the flat surface of the upper film and the surface of the lower film covering it are adhesively bonded or welded to one another.
  • the upper film has a larger one than the lower film Tensile strength. The difference in tensile strength of the two films according to the invention is designed such that the lower film can be torn as a result of a pressure exerted on the bulge in the upper film and, via this, on the medicament or food supplement, such that the medicament or food supplement passes through the lower film can be pressed into the interior of the liquid container and the upper film cannot be torn by the pressure exerted.
  • the upper and lower film can be a plastic film made of polymers, copoly mers or polymer blends.
  • the upper film can be thermoplastic.
  • the top film can also be selected from the group consisting of a polyethylene, a polyethylene copolymer, a polyethylene terephthalate, a polypropylene, a polypropylene copolymer and mixtures thereof.
  • the lower film can comprise an aluminum film, an aluminum film coated on one or both sides or a brittle polymer film.
  • the closure also expediently has a pull tab which projects beyond the collar-shaped edge flange and is formed on the peripheral edge of the upper film or on the peripheral edge of the upper and lower films.
  • An important advantage of the invention is that the medicament or the food supplement and the liquid required for ingestion are contained in a single package, so that the separate carrying or procurement of ingestion liquid is not necessary. Due to the aseptic and liquid-tight arrangement of the medication or the nutritional supplement within the container closure, separate storage of both components is achieved until use, so that a longer shelf life can be achieved. Pushing through the medication or nutritional supplement by means of the lower film into the interior of the liquid container when the container is closed advantageously enables the aseptic production of a dispersion or suspension, which is generally preferred by consumers as a liquid administration form. Ultimately, the invention also enables precise dosing of medication or food supplements and the liquid in the container without great effort.
  • Fig. 1 - a front view of the liquid container with the closure according to the invention
  • Figure 2 the upper part of the liquid container with the closure according to the invention and the medicament or food supplement in tablet form in section.
  • the closure according to the invention consists of two films 2 and 4 arranged one above the other, between which a cavity is formed for receiving a medicament or nutritional supplement 3.
  • This cavity is formed by a centrally arranged, convex, cup-shaped bulge 8 in the upper film 2 and by the lower film 4 covering the flat side of the upper film 2.
  • the closure formed in this way is connected in a liquid-tight manner to a collar-shaped edge flange 7 formed on the opening of the liquid container 6.
  • the flat surface of the upper film 2 and the surface of the lower film 4 covering this are connected to one another at least in part by gluing or welding.
  • the upper and lower Sheets 2 and 4 are only glued or welded together at their peripheral edge.
  • This embodiment is primarily used for liquid containers with a small width of the container opening.
  • the flat surface of the upper film 2 and the surface of the lower film 4 covering this are glued or welded to one another over the surface.
  • the closure also has a pull tab 5 projecting over the edge flange 7, which is formed on the peripheral edge of the upper film 2 or on the peripheral edge of the upper and lower films 2 and 4.
  • the upper and lower foils 2 and 4 are detachably glued to one another and the lower foil 4 is welded to the edge flange 7 or glued inseparably.
  • the dispersion or suspension in the liquid container 6 can be absorbed, for example, by means of a drinking straw which is introduced into the crack in the lower film 4.
  • both foils can be pulled off together from the edge flange 7 and the liquid container 6 can thus be opened completely.
  • the upper and lower foils 2 and 4 are welded to one another or permanently bonded and the lower foil 4 is releasably glued to the edge flange 7.
  • the upper film 2 has a greater tear resistance than the lower film 4.
  • the difference in tensile strength of the Both foils 2 and 4 are designed such that the lower foil 4 not only tears as a result of a pressure exerted on the bulge 8 in the upper foil 2 and via this on the medicament or food supplement 3, but also tears open such that the medicament or food supplement
  • the bulge 8 is merely bent or crumpled by the pressure exerted, the upper film 2 not tearing.
  • the tensile strength of films 2 and 4 is to be designed depending on the film material used, the inside width of the container opening and the film thickness. However, the thickness of the foils is always greater than 0.015 mm.
  • the foils 2 and 4 consist of a food-safe material, for example according to the US regulation FDA Regulations 21 CFR, 177.1520 or according to the European Directive 90/128 / EEC, Appendix 2, Section A.
  • the upper and the lower film 2 and 4 a plastic film made of polymers, copolymers or polymer blends, such as PE, LDPE, MDPE, HDPE, LLDPE, PET and PP.
  • the upper film 2 is thermoplastic. According to another embodiment variant, the upper film 2 is selected from the group consisting of a polyethylene, a polyethylene copolymer, a polyethylene terephthalate, a polypropylene, a polypropylene copolymer and mixtures thereof. According to a further embodiment variant, the lower film is
  • the medicament or food supplement 3 is shown in tablet form.
  • the tablet form is very advantageous for pushing through the lower film 4.
  • the medicament or food supplement 3 can also be in powder or liquid form.
  • the inside width is Container opening 20 mm and the width of the edge flange 3.5 mm.
  • the upper film 2 consists of polyethylene with a thickness of 0.15 mm and the lower film 4 made of aluminum with a thickness of 0.075 mm.
  • the upper and lower films 2 and 4 are welded or sealed to one another at their peripheral edge and the lower film 4 is releasably glued to the edge flange 7.
  • the pull tab 5 is formed on the peripheral edge of the upper and lower foils 2 and 4.
  • the inside width of the container opening is 70 mm and the width of the edge flange is 6 mm.
  • the upper film 2 is a polypropylene film with a thickness of 0.2 mm and the lower film 4 is a double-sided plastic-coated aluminum film with a thickness of 0.1 mm.
  • the flat surface of the upper film 2 and the surface of the lower film 4 covering it is adhesively bonded to one another in a planar manner.
  • the lower film 4 is welded to the edge flange 7 and the pull tab 5 is formed on the upper film 2.
  • closure according to the invention is handled in the following way:
  • both foils 2 and 4 are pulled off together and simultaneously from the edge flange 7 (see FIG. 3, arrow B) and the liquid container 6 thereby 8 fully open. If the pull tab 5 is only formed on the upper film 2, only the upper film 2 is pulled off and the lower film 4 remains firmly connected to the edge flange 7. The dispersion or suspension can be taken up by means of a drinking straw.
  • the user is, of course, at liberty to forego pushing the medication or food supplement 3 through the lower film 4 and producing a dispersion or suspension.
  • the upper and lower films 2 and 4 are pulled off together from the edge flange 7, the medicament or food supplement 3 is pressed through the lower film 4 and then taken together with the liquid 1 or by drinking the liquid 1 again.

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Mechanical Engineering (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Packages (AREA)
  • Centrifugal Separators (AREA)

Abstract

The invention relates to a seal for containers of liquids. The inventive seal is connected to an edge flange (7) which is moulded onto the opening of the container (6), in such a way that the connection is liquid tight. The seal consists of two films (2,4) located one above the other. A hollow space for accommodating a medicament or a nutritional supplement (3) is provided between the two films. Said hollow space is formed by a central, convex, cup-shaped rounded section (8) in the top film (2) and by the bottom film (4) covering the flat side of the top film (2). The flat surface of the top film (2) and the surface of the bottom film (4) covering the same are at least partially joined by sticking or welding. The top film (2) is more resistant to tearing than the bottom film (4). The difference in tear resistance between the two films (2, 4) is such that when pressure is applied to the rounded section (8) and hereby to the medicament or nutritional supplement (3), the bottom film (4) can be broken whilst the top film cannot.

Description

Verschluß für FlüssigkeitsbehälterClosure for liquid containers
Es sind bereits Behälter zur Aufnahme von Getränken oder Nahrungsmitteln bekannt, an deren Öffnung ein kragenförmiger Randflansch angeformt ist. Der Behälterverschluß besteht dabei aus einer Folie, vorzugsweise einer Aluminiumfolie, die mit dem Randflansch lösbar und flüssigkeitsdicht verbunden ist. Regelmäßig ist auch eine Lasche vorgesehen, die über den Randflansch hervorsteht und die ein Abziehen der Folie von der Behälteröffnung ermöglicht.Containers for holding beverages or food are already known, at the opening of which a collar-shaped edge flange is molded. The container closure consists of a film, preferably an aluminum film, which is detachably and liquid-tightly connected to the edge flange. A tab is also regularly provided, which protrudes beyond the edge flange and which enables the film to be pulled off the container opening.
Bekannt sind auch Durchdrückverpackungen, die auch als Bli- sterverpackungen bezeichnet werden, zur Aufnahme von Medikamenten oder Nahrungsergänzungsmitteln in Form von Tabletten, Pillen oder Dragees. Diese Verpackungen bestehen aus zwei übereinander angeordneten und miteinander verbundenen Folien, wobei in der oberen Folie konvexe Ausbuchtungen zur Aufnahme eines Medikaments oder eines Nahrungsergänzungsmittels in Tablettenform ausgebildet sind und die ebene Seite der oberen Folie durch die untere Folie abgedeckt ist. Dabei ist die obere Folie vorwiegend eine Kunststoffolie und die untere Folie eine Aluminiumfolie.Press-through packaging, which is also known as blister packaging, for receiving medicaments or food supplements in the form of tablets, pills or dragees is also known. These packages consist of two films arranged one above the other and connected to one another, convex bulges for receiving a medicament or a food supplement in tablet form are formed in the upper film and the flat side of the upper film is covered by the lower film. The upper film is primarily a plastic film and the lower film is an aluminum film.
Beim Gebrauch des Medikaments oder des Nahrungsergänzungsmittels wird dieses durch Druck auf die Ausbuchtung durch die untere Folie hindurchgedrückt und zusammen mit einer Flüssigkeit oder durch Nachtrinken einer Flüssigkeit eingenommen. Ein Nachteil dieser bekannten Durchdrückverpackung besteht darin, daß durch den Kontakt des Medikaments mit der Umgebungsluft oder der Berührung mit den Händen dessen Keimfreiheit nicht mehr gewährleistet ist.When using the medicament or the nutritional supplement, it is pressed through the lower film by pressure on the bulge and taken together with a liquid or by drinking a liquid afterwards. A disadvantage of this known push-through packaging is that the sterility is no longer guaranteed by the contact of the medication with the ambient air or the contact with the hands.
Nachteilig ist auch, daß in manchen Situationen, beispielsweise bei Reisen nicht immer eine Flüssigkeit für die Einnahme des Medikaments zur Verfügung steht oder anderenfalls separat mitgeführt werden muß.It is also disadvantageous that in some situations, for example when traveling, a liquid is not always available for taking the medication, or else it must be carried separately.
Viele Menschen, insbesondere aber alte Menschen, nehmen Medikamente oder Nahrungsergänzungsmittel in fester Form nur ungern ein, so daß eine flüssige Darreichungsform allgemein bevorzugt wird. Nun gibt es auch Medikamente, die in gelösterMany people, especially old people, are reluctant to take medication or nutritional supplements in solid form, so that a liquid dosage form is generally preferred. Now there are drugs that are in solution
EI REGEL 26) Form relativ instabil und nicht längere Zeit lagerfähig sind oder die ihre Wirkungen verändern, so daß die flüssige Darreichungsform erst bei Bedarf hergestellt werden muß. Dieses ist aufwendig, zumal mitunter eine genaue Dosierung zwischen dem Medikament und der Flüssigkeit einzuhalten und eine keimfreie Herstellung zu sichern ist.EGG RULE 26) Form are relatively unstable and can not be stored for a long time or change their effects, so that the liquid dosage form only has to be prepared if necessary. This is complex, especially since an exact dosage between the medication and the liquid must sometimes be observed and a germ-free production must be ensured.
Aufgabe der vorliegenden Erfindung ist es deshalb, einen Verschluß für Flüssigkeitsbehälter zu schaffen, der mit einem, an der Öffnung des Flüssigkeitsbehälters angeformten kragenförmi- gen Randflansch lösbar aber flüssigkeitsdicht verbunden ist und der eine keimfreie und eine gegenüber der äußeren Umgebung als auch gegenüber dem Behälterinnenraum dicht verschlossene Aufbewahrung eines Medikaments oder eines Nahrungsergänzungsmittels bis zu seinem Gebrauch zusammen mit einer Flüssigkeit und der auch die Herstellung einer Dispersion oder Suspension aus dem Medikament bzw. Nahrungsergänzungsmittel und der im Behälter befindlichen Flüssigkeit vor dem Öffnen des Flüssigkeitsbehälters ermöglicht.The object of the present invention is therefore to create a closure for liquid containers which is detachably but liquid-tightly connected to a collar-shaped edge flange formed on the opening of the liquid container and which is germ-free and sealed against the external environment and also against the container interior sealed storage of a medicament or nutritional supplement until it is used together with a liquid and which also enables the preparation of a dispersion or suspension of the medicament or nutritional supplement and the liquid in the container before opening the liquid container.
Erfindungsgemäß wird diese Aufgabe durch zwei übereinander angeordnete Folien gelöst, zwischen denen ein Hohlraum zur Aufnahme des Medikaments oder Nahrungsergänzungsmittels ausgebildet ist. Dabei wird dieser Hohlraum durch eine zentrisch angeordnete, konvexe, napfförmige Ausbuchtung in der oberen Folie und die die ebene Seite der oberen Folie abdeckende untere Folie gebildet. In weiterer Ausbildung der Erfindung ist die ebene Fläche der oberen Folie und die diese abdeckende Fläche der unteren Folie mindestens zum Teil durch Verkleben oder Verschweißen miteinander verbunden.According to the invention, this object is achieved by means of two foils arranged one above the other, between which a cavity is formed for receiving the medicament or food supplement. This cavity is formed by a centrally arranged, convex, cup-shaped bulge in the upper film and the lower film covering the flat side of the upper film. In a further embodiment of the invention, the flat surface of the upper film and the surface of the lower film covering this are at least partially connected to one another by gluing or welding.
Nach einer ersten Ausführungsform ist die obere und die untere Folie nur an ihrem Umfangsrand miteinander verklebt oder verschweißt. Bei einer anderen Ausführungsform ist die ebene Fläche der oberen Folie und die diese abdeckende Fläche der unteren Folie flächig miteinander verklebt oder verschweißt. Die obere Folie weist gegenüber der unteren Folie eine größere Reißfestigkeit auf. Dabei ist die Reißfestigkeitsdifferenz der beiden Folien nach der Erfindung so ausgelegt, daß die untere Folie infolge eines auf die Ausbuchtung in der oberen Folie und über diese auf das Medikament oder Nahrungserganzungsmittel ausgeübten Druckes derart zerreißbar ist, daß das Medikament oder Nahrungserganzungsmittel durch die untere Folie hindurch in das Innere des Flüssigkeitsbehälters drückbar ist und die obere Folie durch den ausgeübten Druck unzerreißbar ist.According to a first embodiment, the upper and the lower film are glued or welded to one another only at their peripheral edge. In another embodiment, the flat surface of the upper film and the surface of the lower film covering it are adhesively bonded or welded to one another. The upper film has a larger one than the lower film Tensile strength. The difference in tensile strength of the two films according to the invention is designed such that the lower film can be torn as a result of a pressure exerted on the bulge in the upper film and, via this, on the medicament or food supplement, such that the medicament or food supplement passes through the lower film can be pressed into the interior of the liquid container and the upper film cannot be torn by the pressure exerted.
Die obere und untere Folie kann eine Kunststoffolie aus Polymeren, Copoly eren oder Polymer-Blends sein.The upper and lower film can be a plastic film made of polymers, copoly mers or polymer blends.
Weiterhin kann die obere Folie thermoplastisch verformbar sein. Die obere Folie kann aber auch aus der Gruppe ausgewählt sein, bestehend aus einem Polyethylen, einem Polyethylen- Mischpolymerisat, einem Polyethylenterephthalat , einem Polypropylen, einem Polypropylen-Mischpolymerisat und Gemischen davon. Hingegen kann die untere Folie eine Aluminiumfolie, eine ein- oder beidseitig beschichtete Aluminiumfolie oder eine spröde Polymerfolie umfassen. Zweckmäßigerweise verfügt der Verschluß auch über eine über den kragenförmigen Randflansch hervorstehende Abziehlasche, die am Umfangsrand der oberen Folie oder am Umfangsrand der oberen und der unteren Folie ausgebildet ist.Furthermore, the upper film can be thermoplastic. The top film can also be selected from the group consisting of a polyethylene, a polyethylene copolymer, a polyethylene terephthalate, a polypropylene, a polypropylene copolymer and mixtures thereof. In contrast, the lower film can comprise an aluminum film, an aluminum film coated on one or both sides or a brittle polymer film. The closure also expediently has a pull tab which projects beyond the collar-shaped edge flange and is formed on the peripheral edge of the upper film or on the peripheral edge of the upper and lower films.
Ein wesentlicher Vorteil der Erfindung besteht darin, daß das Medikament oder das Nahrungserganzungsmittel und die zur Einnahme benötigte Flüssigkeit in einer einzigen Verpackung enthalten ist, so daß die separate Mitführung oder Beschaffung von Einnahmeflüssigkeit entfällt. Durch die keimfreie und flüssigkeitsdichte Anordnung des Medikaments oder des Nahrungsergänzungsmittels innerhalb des Behälterverschlusses wird eine getrennte Aufbewahrung beider Komponenten bis zum Gebrauch erzielt, wodurch eine längere Lagerfähigkeit erreichbar ist. Das Durchdrücken des Medikamentes bzw. des Nahrungsergänzungs- mittels durch die untere Folie in das Innere des Flüssigkeitsbehälters bei geschlossenem Behälter ermöglicht in vorteilhafter Weise die keimfreie Herstellung einer Dispersion oder Suspension, die als flüssige Darreichungsform von den Verbrauchern allgemein bevorzugt wird. Letzlich ist durch die Erfindung auch eine genaue Dosierung von Medikament oder Nahrungserganzungsmittel und der im Behälter befindlichen Flüssigkeit ohne großen Arbeitsaufwand möglich.An important advantage of the invention is that the medicament or the food supplement and the liquid required for ingestion are contained in a single package, so that the separate carrying or procurement of ingestion liquid is not necessary. Due to the aseptic and liquid-tight arrangement of the medication or the nutritional supplement within the container closure, separate storage of both components is achieved until use, so that a longer shelf life can be achieved. Pushing through the medication or nutritional supplement by means of the lower film into the interior of the liquid container when the container is closed advantageously enables the aseptic production of a dispersion or suspension, which is generally preferred by consumers as a liquid administration form. Ultimately, the invention also enables precise dosing of medication or food supplements and the liquid in the container without great effort.
Die Erfindung soll nachstehend anhand der dazugehörigen Zeichnung näher erläutert werden. Es zeigen:The invention will be explained below with reference to the accompanying drawing. Show it:
Fig. 1 - eine Vorderansicht des Flüssigkeitsbehälters mit dem erfindungsgemäßen Verschluß;Fig. 1 - a front view of the liquid container with the closure according to the invention;
Fig. 2 - den oberen Teil des Flüssigkeitsbehälters mit dem erfindungsgemäßen Verschluß und dem Medikament oder Nahrungserganzungsmittel in Tablettenform im Schnitt;Figure 2 - the upper part of the liquid container with the closure according to the invention and the medicament or food supplement in tablet form in section.
Fig. 3 - den oberen Teil des Flüssigkeitsbehälters nachFig. 3 - the upper part of the liquid container after
Fig. 2 mit dem durch die untere Folie hindurchgedrückten Medikament oder Nahrungserganzungsmittel in Tablettenform im Schnitt.Fig. 2 with the medicine or food supplement in tablet form pressed through the lower film in section.
Wie aus Fig. 2 und 3 ersichtlich ist, besteht der erfindungsgemäße Verschluß aus zwei übereinander angeordneten Folien 2 und 4, zwischen denen ein Hohlraum zur Aufnahme eines Medikaments oder Nahrungsergänzungsmittels 3 ausgebildet ist. Dieser Hohlraum wird durch eine zentrisch angeordnete, konvexe, napfförmige Ausbuchtung 8 in der oberen Folie 2 und durch die die ebene Seite der oberen Folie 2 abdeckende untere Folie 4 gebildet. Der so ausgebildete Verschluß ist mit einem, an der Öffnung des Flüssigkeitsbehälters 6 angeformten kragenförmigen Randflansch 7 flüssigkeitsdicht verbunden. Weiterhin ist die ebene Fläche der oberen Folie 2 und die diese abdeckende Fläche der unteren Folie 4 mindestens zu einem Teil durch Verkleben oder Verschweißen miteinander verbunden. Nach einer Ausführungsform des Verschlusses ist die obere und untere Folie 2 und 4 nur an ihrem Umfangsrand miteinander verklebt oder verschweißt. Diese Ausführungsform wird vorrangig für Flüssigkeitsbehälter mit einer geringen Weite der Behälteröffnung verwendet. Für Behälteröffnungen mit einer größeren Weite ist nach einer anderen Ausführungsform die ebene Fläche der oberen Folie 2 und die diese abdeckende Fläche der unteren folie 4 flächig miteinander verklebt oder verschweißt. Der Verschluß weist auch eine über den Randflansch 7 hervorstehende Abziehlasche 5 auf, die am Umfangsrand der oberen Folie 2 oder am Umfangsrand der oberen und der unteren Folie 2 und 4 ausgebildet ist. Durch die Ausbildung der AbziehlascheAs can be seen from FIGS. 2 and 3, the closure according to the invention consists of two films 2 and 4 arranged one above the other, between which a cavity is formed for receiving a medicament or nutritional supplement 3. This cavity is formed by a centrally arranged, convex, cup-shaped bulge 8 in the upper film 2 and by the lower film 4 covering the flat side of the upper film 2. The closure formed in this way is connected in a liquid-tight manner to a collar-shaped edge flange 7 formed on the opening of the liquid container 6. Furthermore, the flat surface of the upper film 2 and the surface of the lower film 4 covering this are connected to one another at least in part by gluing or welding. According to one embodiment of the closure, the upper and lower Sheets 2 and 4 are only glued or welded together at their peripheral edge. This embodiment is primarily used for liquid containers with a small width of the container opening. For container openings with a larger width, according to another embodiment, the flat surface of the upper film 2 and the surface of the lower film 4 covering this are glued or welded to one another over the surface. The closure also has a pull tab 5 projecting over the edge flange 7, which is formed on the peripheral edge of the upper film 2 or on the peripheral edge of the upper and lower films 2 and 4. By forming the pull tab
5 an der oberen Folie 2 wird erreicht, daß nur diese vom Randflansch 7 abgezogen werden kann und die untere Folie 4 mit dem Randflansch 7 fest verbunden bleibt. Dazu ist die obere und die untere Folie 2 und 4 lösbar miteinander verklebt und die untere Folie 4 mit dem Randflansch 7 verschweißt oder unlösbar verklebt.5 on the upper film 2 is achieved that only this can be removed from the edge flange 7 and the lower film 4 remains firmly connected to the edge flange 7. For this purpose, the upper and lower foils 2 and 4 are detachably glued to one another and the lower foil 4 is welded to the edge flange 7 or glued inseparably.
Diese Ausführungsvariante ermöglicht, den FlüssigkeitsbehälterThis variant enables the liquid container
6 während der Einnahme der zuvor hergestellten Dispersion oder Suspension aus dem Medikament oder dem Nahrungserganzungsmittel 3 und der Flüssigkeit 1, beispielsweise Wasser im wesentlichen verschlossen zu halten, was aus hygienischen Gründen empfehlenswert ist. Hierbei kann die im Flüssigkeitsbehälter 6 befindliche Dispersion oder Suspension zum Beispiel mittels eines Trinkhalmes aufgenommen werden, der in den Riß in der unteren Folie 4 eingeführt wird.6 to keep essentially closed while taking the previously prepared dispersion or suspension of the medicament or the food supplement 3 and the liquid 1, for example water, which is recommended for hygienic reasons. Here, the dispersion or suspension in the liquid container 6 can be absorbed, for example, by means of a drinking straw which is introduced into the crack in the lower film 4.
Wenn die Abziehlasche 5 am Umfangsrand der oberen und der unteren Folie 2 und 4 ausgebildet ist, können beide Folien gemeinsam vom Randflansch 7 abgezogen und damit der Flüssigkeitsbehälter 6 vollständig geöffnet werden. Um dieses zu ermöglichen, ist die obere und die untere Folie 2 und 4 miteinander verschweißt oder unlösbar verklebt und die untere Folie 4 mit dem Randflansch 7 lösbar verklebt. Die obere Folie 2 weist gegenüber der unteren Folie 4 eine größere Reißfestigkeit auf. Die Reißfestigkeitsdifferenz der beiden Folien 2 und 4 ist dabei so ausgelegt, daß die untere Folie 4 infolge eines auf die Ausbuchtung 8 in der oberen Folie 2 und über diese auf das Medikament oder Nahrungserganzungsmittel 3 ausgeübten Druckes nicht nur einreißt, sondern so aufreißt, daß das Medikament oder NahrungserganzungsmittelIf the pull tab 5 is formed on the circumferential edge of the upper and lower foils 2 and 4, both foils can be pulled off together from the edge flange 7 and the liquid container 6 can thus be opened completely. To make this possible, the upper and lower foils 2 and 4 are welded to one another or permanently bonded and the lower foil 4 is releasably glued to the edge flange 7. The upper film 2 has a greater tear resistance than the lower film 4. The difference in tensile strength of the Both foils 2 and 4 are designed such that the lower foil 4 not only tears as a result of a pressure exerted on the bulge 8 in the upper foil 2 and via this on the medicament or food supplement 3, but also tears open such that the medicament or food supplement
3 durch die untere Folie 4 hindurch in das Innere des Flüssigkeitsbehälters 6 gedrückt werden kann. Durch den ausgeübten Druck wird die Ausbuchtung 8 lediglich durchgebogen oder geknautscht, wobei die obere Folie 2 nicht zerreißt.3 can be pressed through the lower film 4 into the interior of the liquid container 6. The bulge 8 is merely bent or crumpled by the pressure exerted, the upper film 2 not tearing.
Die Reißfestigkeit der Folien 2 und 4 ist in Abhängigkeit von dem verwendeten Folienmaterial, von der lichten Weite der Behälteröffnung und von der Foliendicke auszulegen. Die Dicke der Folien ist aber stets größer als 0,015 mm. Die Folien 2 und 4 bestehen aus einem lebensmitteltechnisch unbedenklichen Material, beispielsweise gemäß der US-Vorschrift FDA-Regulations 21 CFR, 177.1520 oder gemäß der europäischen Richtlinie 90/128/EWG, Anlage 2, Abschnitt A. Gemäß einer Ausführungsvariante ist die obere und die untere Folie 2 und 4 eine Kunststoffolie aus Polymeren, Copolymeren oder Polymer-Blends, wie beispielsweise PE, LDPE, MDPE, HDPE, LLDPE, PET und PP.The tensile strength of films 2 and 4 is to be designed depending on the film material used, the inside width of the container opening and the film thickness. However, the thickness of the foils is always greater than 0.015 mm. The foils 2 and 4 consist of a food-safe material, for example according to the US regulation FDA Regulations 21 CFR, 177.1520 or according to the European Directive 90/128 / EEC, Appendix 2, Section A. According to one embodiment variant, the upper and the lower film 2 and 4 a plastic film made of polymers, copolymers or polymer blends, such as PE, LDPE, MDPE, HDPE, LLDPE, PET and PP.
Die obere Folie 2 ist thermoplastisch verformbar. Nach einer anderen Ausführungsvariante ist die obere Folie 2 aus der Gruppe ausgewählt, bestehend aus einem Polyethylen, einem Polyethylen-Mischpolymerisat, einem Polyethylenterephthalat, einem Polypropylen, einem Polypropylen-Mischpolymerisat und Gemischen davon. Nach einer weiteren Ausführungsvariante ist die untere FolieThe upper film 2 is thermoplastic. According to another embodiment variant, the upper film 2 is selected from the group consisting of a polyethylene, a polyethylene copolymer, a polyethylene terephthalate, a polypropylene, a polypropylene copolymer and mixtures thereof. According to a further embodiment variant, the lower film is
4 eine Aluminiumfolie, eine ein- oder beidseitig beschichtete Aluminiumfolie oder eine spröde Polymerfolie.4 an aluminum foil, an aluminum foil coated on one or both sides or a brittle polymer foil.
In Fig. 2 und 3 ist das Medikament oder Nahrungserganzungsmittel 3 in Tablettenform dargestellt. Die Tablettenform ist für das Durchdrücken durch die untere Folie 4 sehr vorteilhaft. Das Medikament oder Nahrungserganzungsmittel 3 kann aber auch in pulverförmiger oder flüssiger Form vorliegen. Bei einem Ausführungsbeispiel beträgt die lichte Weite der Behälteröffnung 20 mm und die Breite des Randflansches 3,5 mm. Die obere Folie 2 besteht aus Polyethylen mit einer Dicke von 0,15 mm und die untere Folie 4 aus Aluminium mit einer Dicke von 0,075 mm. Die obere und untere Folie 2 und 4 ist an ihrem Umfangsrand miteinander verschweißt oder versiegelt und die untere Folie 4 mit dem Randflansch 7 lösbar verklebt. Die Abziehlasche 5 ist am Umfangsrand der oberen und der unteren Folie 2 und 4 ausgebildet.2 and 3, the medicament or food supplement 3 is shown in tablet form. The tablet form is very advantageous for pushing through the lower film 4. However, the medicament or food supplement 3 can also be in powder or liquid form. In one embodiment, the inside width is Container opening 20 mm and the width of the edge flange 3.5 mm. The upper film 2 consists of polyethylene with a thickness of 0.15 mm and the lower film 4 made of aluminum with a thickness of 0.075 mm. The upper and lower films 2 and 4 are welded or sealed to one another at their peripheral edge and the lower film 4 is releasably glued to the edge flange 7. The pull tab 5 is formed on the peripheral edge of the upper and lower foils 2 and 4.
Bei einem anderen Ausführungsbeispiel beträgt die lichte Weite der Behälteröffnung 70 mm und die Breite des Randflansches 6 mm. Die obere Folie 2 ist eine Polypropylen-Folie mit einer Dicke von 0,2 mm und die untere Folie 4 eine beidseitig kunststoffbeschichtete Aluminiumfolie mit einer Dicke von 0,1 mm. Die ebene Fläche der oberen Folie 2 und die diese abdeckende Fläche der unteren Folie 4 ist flächig miteinander lösbar verklebt. Die untere Folie 4 ist mit dem Randflansch 7 verschweißt und die Abziehlasche 5 an der oberen Folie 2 ausgebildet.In another embodiment, the inside width of the container opening is 70 mm and the width of the edge flange is 6 mm. The upper film 2 is a polypropylene film with a thickness of 0.2 mm and the lower film 4 is a double-sided plastic-coated aluminum film with a thickness of 0.1 mm. The flat surface of the upper film 2 and the surface of the lower film 4 covering it is adhesively bonded to one another in a planar manner. The lower film 4 is welded to the edge flange 7 and the pull tab 5 is formed on the upper film 2.
Die Handhabung des erfindungsgemäßen Verschlusses erfolgt auf folgende Weise:The closure according to the invention is handled in the following way:
Es wird Druck, beispielsweise mit einem Finger auf die Ausbuchtung 8 in der oberen Folie 2 ausgeübt und das Medikament oder Nahrungserganzungsmittel 3 durch die untere Folie 4 hindurchgedrückt, wodurch es in die im Flüssigkeitsbehälter 6 befindliche Flüssigkeit 1 fällt, was in Fig. 3 durch den Pfeil A dargestellt ist. Durch Schütteln des Flüssigkeitsbehälters 6 wird die gewünschte Dispersion oder Suspension aus dem Medikament oder Nahrungserganzungsmittel 3 und der Flüssigkeit 1 hergestellt.Pressure is exerted, for example with a finger, on the bulge 8 in the upper film 2 and the medicament or food supplement 3 is pressed through the lower film 4, as a result of which it falls into the liquid 1 in the liquid container 6, which in FIG Arrow A is shown. The desired dispersion or suspension of the medicament or food supplement 3 and the liquid 1 is produced by shaking the liquid container 6.
Mittels der am Umfangsrand der oberen und der unteren Folie 2 und 4 ausgebildeten Abziehlasche 5 werden beide Folien 2 und 4 gemeinsam und gleichzeitig vom Randflansch 7 abgezogen (siehe Fig. 3, Pfeil B) und der Flüssigkeitsbehälter 6 dadurch 8 vollständig geöffnet. Ist die Abziehlasche 5 nur an der oberen Folie 2 ausgebildet, so wird nur die obere Folie 2 abgezogen und die untere Folie 4 bleibt mit dem Randflansch 7 fest verbunden. Hierbei kann die Dispersion oder Suspension mittels eines Trinkhalmes aufgenommen werden.By means of the pull tab 5 formed on the peripheral edge of the upper and lower foils 2 and 4, both foils 2 and 4 are pulled off together and simultaneously from the edge flange 7 (see FIG. 3, arrow B) and the liquid container 6 thereby 8 fully open. If the pull tab 5 is only formed on the upper film 2, only the upper film 2 is pulled off and the lower film 4 remains firmly connected to the edge flange 7. The dispersion or suspension can be taken up by means of a drinking straw.
Es bleibt dem Benutzer selbstverständlich unbenommen, auf das Durchdrücken des Medikaments oder Nahrungsergänzungsmittels 3 durch die untere Folie 4 und die Herstellung einer Dispersion oder Suspension zu verzichten. In diesem Falle wird die obere und untere Folie 2 und 4 gemeinsam vom Randflansch 7 abgezogen, das Medikament oder Nahrungserganzungsmittel 3 durch die untere Folie 4 hindurchgedrückt und dann zusammen mit der Flüssigkeit 1 oder durch Nachtrinken der Flüssigkeit 1 eingenommen. The user is, of course, at liberty to forego pushing the medication or food supplement 3 through the lower film 4 and producing a dispersion or suspension. In this case, the upper and lower films 2 and 4 are pulled off together from the edge flange 7, the medicament or food supplement 3 is pressed through the lower film 4 and then taken together with the liquid 1 or by drinking the liquid 1 again.

Claims

Patentansprüche claims
1. Verschluß für Flüssigkeitsbehälter, der mit einem, an der Öffnung des Flüssigkeitsbehälters (6) angeformten kragenförmi- gen Randflansch (7) flüssigkeitsdicht verbunden ist, gekennzeichnet durch zwei übereinander angeordnete Folien (2, 4), zwischen denen ein Hohlraum zur Aufnahme eines Medikaments oder Nahrungsergänzungsmittels (3) ausgebildet ist, der durch eine zentrisch angeordnete, konvexe, napfförmige Ausbuchtung (8) in der oberen Folie (2) und durch die die ebene Seite der oberen Folie (2) abdeckende untere Folie (4) gebildet ist, und die ebene Fläche der oberen Folie (2) und die diese abdeckende Fläche der unteren Folie (4) mindestens zu einem Teil durch Verkleben oder Verschweißen miteinander verbunden ist, wobei beide Folien (2, 4) eine solche Reißfestigkeitsdifferenz auf¬ weisen, daß die untere Folie (4) infolge eines auf die Ausbuchtung (8) der oberen Folie (2) und über diese auf das Medikament oder Nahrungserganzungsmittel ( 3 ) ausgeübten Druckes derart zerreißbar ist, daß das Medikament oder Nahrungserganzungsmittel ( 3 ) durch die untere Folie ( 4 ) hindurch in das Innere des Flüssigkeitsbehälters (6) drückbar ist und die obere Folie (2) durch den ausgeübten Druck unzerreißbar ist.1. A closure for liquid containers, which is connected in a liquid-tight manner to a collar-shaped edge flange (7) formed on the opening of the liquid container (6), characterized by two foils (2, 4) arranged one above the other, between which a cavity for receiving a medicament or food supplement (3) which is formed by a centrally arranged, convex, cup-shaped bulge (8) in the upper film (2) and by the lower film (4) covering the flat side of the upper film (2), and the flat surface of the top sheet (2) and this covering surface is connected to the lower film (4) at least in part by bonding or welding to each other, wherein both films (2, 4) have such a tensile strength difference on ¬ that the lower Foil (4) as a result of a pressure exerted on the bulge (8) of the upper foil (2) and via this on the medicament or food supplement (3) It can be torn apart so that the medicament or food supplement (3) can be pressed through the lower film (4) into the interior of the liquid container (6) and the upper film (2) cannot be torn by the pressure exerted.
2. Verschluß für Flüssigkeitsbehälter nach Anspruch 1, dadurch gekennzeichnet, daß die obere und untere Folie (2, 4) eine Kunststoffolie aus Polymeren, Copolymeren oder Polymer- Blends ist.2. Closure for liquid container according to claim 1, characterized in that the upper and lower film (2, 4) is a plastic film made of polymers, copolymers or polymer blends.
3. Verschluß für Flüssigkeitsbehälter nach Anspruch 1 oder 2, dadurch gekennzeichnet, daß die obere Folie (2) thermopla¬ stisch verformbar ist.3. Closure for liquid containers according to claim 1 or 2, characterized in that the upper film (2) is thermoplastic ¬ stisch deformable.
4. Verschluß für Flüssigkeitsbehälter nach Anspruch 3, dadurch gekennzeichnet, daß die obere Folie (2) aus der Gruppe ausgewählt ist, bestehend aus einem Polyethylen, einem Poly- 10 ethylen-Mischpolymerisat, einem Polyethylenterephthalat , einem Polypropylen, einem Polypropylen-Mischpolymerisat und Gemischen davon.4. Closure for liquid containers according to claim 3, characterized in that the upper film (2) is selected from the group consisting of a polyethylene, a poly 10 ethylene copolymer, a polyethylene terephthalate, a polypropylene, a polypropylene copolymer and mixtures thereof.
5. Verschluß für Flüssigkeitsbehälter nach Anspruch 1, dadurch gekennzeichnet, daß die untere Folie (4) eine Aluminiumfolie, eine ein- oder beidseitig beschichtete Aluminiumfolie oder eine spröde Polymerfolie umfaßt.5. A closure for a liquid container according to claim 1, characterized in that the lower film (4) comprises an aluminum film, an aluminum film coated on one or both sides or a brittle polymer film.
6. Verschluß für Flüssigkeitsbehälter nach einem der Ansprüche 1 bis 5, dadurch gekennzeichnet, daß die obere und untere Folie (2, 4) an ihrem Umfangsrand miteinander verklebt oder verschweißt ist.6. Closure for liquid container according to one of claims 1 to 5, characterized in that the upper and lower film (2, 4) is glued or welded together at their peripheral edge.
7. Verschluß für Flüssigkeitsbehälter nach einem der Ansprüche 1 bis 5, dadurch gekennzeichnet, daß die ebene Fläche der oberen Folie (2) und die diese abdeckende Fläche der unteren Folie (4) flächig miteinander verklebt oder verschweißt ist.7. Closure for liquid containers according to one of claims 1 to 5, characterized in that the flat surface of the upper film (2) and this covering surface of the lower film (4) is glued or welded to one another.
8. Verschluß für Flüssigkeitsbehälter nach einem oder mehreren der Ansprüche 1 bis 7, dadurch gekennzeichnet, daß am Umfangsrand der oberen Folie ( 2 ) eine über den kragenförmigen Randflansch (7) hervorstehende Abziehlasche (5) ausgebildet ist.8. Closure for liquid container according to one or more of claims 1 to 7, characterized in that on the peripheral edge of the upper film (2) is formed over the collar-shaped edge flange (7) projecting pull tab (5).
9. Verschluß für Flüssigkeitsbehälter nach einem oder mehreren der Ansprüche 1 bis 7, dadurch gekennzeichnet, daß am Umfangsrand der oberen und unteren Folie (2, 4) eine über den kragenförmigen Randflansch (7) hervorstehende Abziehlasche (5) ausgebildet ist.9. closure for liquid container according to one or more of claims 1 to 7, characterized in that on the peripheral edge of the upper and lower film (2, 4) is formed over the collar-shaped edge flange (7) projecting pull tab (5).
10. Verschluß für Flüssigkeitsbehälter nach Anspruch 1, dadurch gekennzeichnet, daß die obere Folie (2) eine Folie mit hoher Reißfestigkeit und die untere Folie (4) eine Folie mit geringer Reißfestigkeit ist. 10. Closure for liquid containers according to claim 1, characterized in that the upper film (2) is a film with high tear strength and the lower film (4) is a film with low tear strength.
EP99930899A 1998-01-21 1999-01-20 Liquid container with seal Expired - Lifetime EP1144265B1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE29800794U 1998-01-21
DE29800794U DE29800794U1 (en) 1998-01-21 1998-01-21 Closure for liquid containers
PCT/DE1999/000172 WO1999037553A1 (en) 1998-01-21 1999-01-20 Seal for a liquid container

Publications (2)

Publication Number Publication Date
EP1144265A2 true EP1144265A2 (en) 2001-10-17
EP1144265B1 EP1144265B1 (en) 2005-09-07

Family

ID=8051417

Family Applications (1)

Application Number Title Priority Date Filing Date
EP99930899A Expired - Lifetime EP1144265B1 (en) 1998-01-21 1999-01-20 Liquid container with seal

Country Status (5)

Country Link
EP (1) EP1144265B1 (en)
AU (1) AU2703599A (en)
DE (2) DE29800794U1 (en)
DK (1) DK1144265T3 (en)
WO (1) WO1999037553A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2625117A4 (en) * 2010-10-05 2015-07-29 Kambouris Gillian Anne A blister pack for a container

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPP223498A0 (en) * 1998-03-06 1998-04-02 Southcorp Australia Pty Ltd A container
WO2000024645A1 (en) * 1998-10-26 2000-05-04 Richard David North Tablet package
EP1149026B1 (en) * 1998-11-09 2006-09-06 Fredrick Michael Coory Discharge cap for releasable tablet
EP1648796B1 (en) * 2003-07-30 2011-03-02 Rm Beteiligungs Ag Plastic drinks bottle with blister
ITMI20041332A1 (en) * 2004-07-01 2004-10-01 N G G Medical S P A STRUCTURE OF DISPOSABLE RIGID CONTAINER PARTICULARLY FOR THE COLLECTION OF CONTAMINATED SANITARY LIQUIDS FOR THEIR DISPOSAL IN SEMI-SOLID FORM
DE102005006827A1 (en) 2004-11-04 2006-05-24 Huhtamaki Ronsberg, Zweigniederlassung Der Huhtamaki Deutschland Gmbh & Co. Kg Process for producing a bottle-like or hose-like container, in particular a tubular bag, with a sealed bottom and a correspondingly produced tubular bag
WO2007017911A1 (en) * 2005-08-11 2007-02-15 Vanni Benedetti A process for packing and a package for substances to be mixed immediately prior to use
GB2434353A (en) * 2006-01-18 2007-07-25 Hannah E Giles Knopp Soluble tablet container
US8523837B2 (en) * 2008-10-14 2013-09-03 Mead Johnson Nutrition Company Nutritive substance delivery container
DE102009007860A1 (en) * 2008-11-07 2010-05-12 Huhtamaki Ronsberg, Zweigniederlassung Der Huhtamaki Deutschland Gmbh & Co. Kg container
NL1036822C2 (en) * 2009-04-06 2010-10-07 Boom Packaging B V LID WITH LOCKABLE RESERVOIR AND BAKER OR CUP WITH SUCH LID.
WO2013037615A1 (en) * 2011-09-18 2013-03-21 Edwin Klein Insert body for inserting into or placing on a receiving vessel, and receiving vessel with such an insert body

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1591549A (en) * 1967-11-17 1970-04-27
FR1588967A (en) * 1968-10-02 1970-03-16
ATE55750T1 (en) * 1986-02-03 1990-09-15 Toess Steigmuehle Ag CONTAINER ARRANGEMENT AND THEIR APPLICATION.
US5052553A (en) * 1989-09-27 1991-10-01 Sanctis Attilio J De Container having manually openable closure for mixing
EP0696999A1 (en) * 1993-02-26 1996-02-21 Thues, Maria Multi-compartment container

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See references of WO9937553A1 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2625117A4 (en) * 2010-10-05 2015-07-29 Kambouris Gillian Anne A blister pack for a container

Also Published As

Publication number Publication date
AU2703599A (en) 1999-08-09
WO1999037553A1 (en) 1999-07-29
DE29800794U1 (en) 1998-03-12
DE59912535D1 (en) 2005-10-13
DK1144265T3 (en) 2006-02-06
EP1144265B1 (en) 2005-09-07

Similar Documents

Publication Publication Date Title
DE68914938T2 (en) Self-expanding flexible pouch.
EP2483069B1 (en) Tear-proof packaging composite film and packaging
DE68904788T2 (en) METHOD FOR CLOSING AND OPENING STERILIZABLE CONTAINERS, LIDS FOR CARRYING OUT THIS METHOD AND PRODUCTION METHOD OF THIS LID.
DE102004026980B4 (en) Stand-up pouches with optimized tear properties and process for its production
EP1057749B1 (en) Press-through package
EP2396241B1 (en) Childproof, highly inert individual packaging
DE69231253T2 (en) PACKING SYSTEM FOR FLOWABLE OR SOLID SUBSTANCES
EP2599735B1 (en) Closure film with integrated opening
EP3594144B1 (en) Recyclable bag
EP1838595B1 (en) Film container
DE69506267T2 (en) BLISTER PACK WITH DRYING AGENT
EP1144265B1 (en) Liquid container with seal
DE102004047445A1 (en) Non-resealable packaging for health-endangering products, as well as methods for their production
EP1819603A1 (en) Capsule closure
CH670236A5 (en)
EP2323918A1 (en) Blister pack
DE2751078C3 (en) Container for flowable materials
WO2007118649A1 (en) A packaging which is suitable for microwaves
EP3388364B1 (en) Medical product package
EP1046594B1 (en) Package having a peelable seal and method of manufacturing said package
DE102012006934B3 (en) Sealing disc for induction sealing of a container
DE60220770T2 (en) PACKAGING WITH A CLOSING SYSTEM WITH SHELLS AND METHOD FOR THE PRODUCTION THEREOF
DE9307726U1 (en) Multi-chamber containers with plastic films
WO2006089750A1 (en) Tubular bag with a cover
AT517369B1 (en) Container and bandage from a number of containers

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20010421

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): BE DE DK FR GB GR IE IT LU NL PT

XX Miscellaneous (additional remarks)

Free format text: DERZEIT SIND DIE WIPO-PUBLIKATIONSDATEN A3 NICHT VERFUEGBAR.

PUAK Availability of information related to the publication of the international search report

Free format text: ORIGINAL CODE: 0009015

17Q First examination report despatched

Effective date: 20020712

AK Designated contracting states

Kind code of ref document: A3

Designated state(s): BE DE DK FR GB GR IE IT LU NL PT

GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

RTI1 Title (correction)

Free format text: LIQUID CONTAINER WITH SEAL

GRAS Grant fee paid

Free format text: ORIGINAL CODE: EPIDOSNIGR3

GRAA (expected) grant

Free format text: ORIGINAL CODE: 0009210

AK Designated contracting states

Kind code of ref document: B1

Designated state(s): BE DE DK FR GB GR IE IT LU NL PT

REG Reference to a national code

Ref country code: GB

Ref legal event code: FG4D

Free format text: NOT ENGLISH

XX Miscellaneous (additional remarks)

Free format text: DERZEIT SIND DIE WIPO-PUBLIKATIONSDATEN A3 NICHT VERFUEGBAR.

REG Reference to a national code

Ref country code: IE

Ref legal event code: FG4D

Free format text: LANGUAGE OF EP DOCUMENT: GERMAN

REF Corresponds to:

Ref document number: 59912535

Country of ref document: DE

Date of ref document: 20051013

Kind code of ref document: P

REG Reference to a national code

Ref country code: GR

Ref legal event code: EP

Ref document number: 20050403761

Country of ref document: GR

REG Reference to a national code

Ref country code: DK

Ref legal event code: T3

GBT Gb: translation of ep patent filed (gb section 77(6)(a)/1977)

Effective date: 20060124

ET Fr: translation filed
PLBE No opposition filed within time limit

Free format text: ORIGINAL CODE: 0009261

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT

26N No opposition filed

Effective date: 20060608

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: PT

Payment date: 20070110

Year of fee payment: 9

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: NL

Payment date: 20070117

Year of fee payment: 9

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: GB

Payment date: 20070123

Year of fee payment: 9

Ref country code: DK

Payment date: 20070123

Year of fee payment: 9

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: BE

Payment date: 20070125

Year of fee payment: 9

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: LU

Payment date: 20070126

Year of fee payment: 9

Ref country code: IE

Payment date: 20070126

Year of fee payment: 9

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: DE

Payment date: 20070329

Year of fee payment: 9

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: IT

Payment date: 20070605

Year of fee payment: 9

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: GR

Payment date: 20070123

Year of fee payment: 9

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: FR

Payment date: 20070118

Year of fee payment: 9

BERE Be: lapsed

Owner name: TEUCHERT UWE

Effective date: 20080131

REG Reference to a national code

Ref country code: PT

Ref legal event code: MM4A

Free format text: LAPSE DUE TO NON-PAYMENT OF FEES

Effective date: 20080721

REG Reference to a national code

Ref country code: DK

Ref legal event code: EBP

GBPC Gb: european patent ceased through non-payment of renewal fee

Effective date: 20080120

NLV4 Nl: lapsed or anulled due to non-payment of the annual fee

Effective date: 20080801

REG Reference to a national code

Ref country code: IE

Ref legal event code: MM4A

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: PT

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20080721

Ref country code: NL

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20080801

Ref country code: DE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20080801

REG Reference to a national code

Ref country code: FR

Ref legal event code: ST

Effective date: 20081029

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: GB

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20080120

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: IE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20080121

Ref country code: DK

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20080131

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: BE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20080131

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: FR

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20080131

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: GR

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20080804

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: IT

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20080120

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: LU

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20080120